EF
UTMD icon

Empowered Funds’s Utah Medical Products UTMD Stock Holding History

Empowered Funds’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$225K Sell
3,264
-14
-0.4% -$930 ﹤0.01% 1971
2026
Q1 		$203K Buy
+3,278
New +$207K ﹤0.01% 2017

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Empowered Funds's UTMD Position: Q2 2026 in Review

Empowered Funds reduced its Utah Medical Products (UTMD) stake by 0.43% in Q2 2026, selling an estimated $930 and leaving 3,264 shares worth $225K. The position accounts for ﹤0.01% of the portfolio, ranked #1971.

Empowered Funds first reported a position in UTMD in Q1 2026 and has held it in 2 quarters since. 114 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

  • Empowered Funds held 3,264 shares of Utah Medical Products worth $225K as of Q2 2026.
  • Empowered Funds sold 14 Utah Medical Products shares in Q2 2026, an estimated $930.
  • Utah Medical Products made up ﹤0.01% of Empowered Funds's portfolio in Q2 2026, its #1971 holding.
  • Empowered Funds first reported a position in Utah Medical Products in Q1 2026 and has held it in 2 quarters since.
  • 114 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.